Ossiam’s Apellis Pharmaceuticals APLS Stock Holding History

Ossiam’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-555,953	Closed	-$22.4M	–	683
2026 Q1	$22.4M	Buy	555,953 +124,174	+29%	+$2.68M	0.39%	49
2025 Q4	$10.8M	Sell	431,779 -124,174	-22%	-$2.91M	0.22%	62
2025 Q3	$12.6M	Hold	555,953	–	–	0.16%	110
2025 Q2	$9.62M	Buy	+555,953	New	+$10.3M	0.11%	127

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ossiam's APLS Position: Q2 2026 in Review

Ossiam sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 555,953 shares — an estimated $22.4M sold.

Ossiam first reported a position in APLS in Q2 2025 and held it in 4 quarters. The position peaked at $22.4M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Ossiam reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Ossiam sold 555,953 Apellis Pharmaceuticals shares in Q2 2026, an estimated $22.4M.
Ossiam first reported a position in Apellis Pharmaceuticals in Q2 2025 and held it in 4 quarters.
Ossiam's Apellis Pharmaceuticals position peaked at $22.4M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.